Literature DB >> 29514031

Ambient Temperature and Screening for Nasopharyngeal Cancer.

K C Allen Chan1, Sam W I Chu1, Y M Dennis Lo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29514031     DOI： 10.1056/NEJMc1800433

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Maintenance therapy improves the survival outcomes of patients with metastatic nasopharyngeal carcinoma responding to first-line chemotherapy: a multicentre, randomized controlled clinical study.

Authors:  Ying Lu; Haixin Huang; Hui Yang; Xiaohua Hu; Meilian Liu; Changjie Huang; Xianbin Feng; Xishan Chen; Zhou Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-08       Impact factor: 4.322

2.  An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma.

Authors:  Sik-Kwan Chan; Brian O'Sullivan; Shao Hui Huang; Tin-Ching Chau; Ka-On Lam; Sum-Yin Chan; Chi-Chung Tong; Varut Vardhanabhuti; Dora Lai-Wan Kwong; Chor-Yi Ng; To-Wai Leung; Mai-Yee Luk; Anne Wing-Mui Lee; Horace Cheuk-Wai Choi; Victor Ho-Fun Lee
Journal:  Cancers (Basel)       Date:  2022-04-11       Impact factor: 6.575

3.  Association Between Environmental Factors and Oral Epstein-Barr Virus DNA Loads: A Multicenter Cross-sectional Study in China.

Authors:  Yong-Qiao He; Xiao-Yu Liao; Wen-Qiong Xue; Ya-Fei Xu; Feng-Hua Xu; Fang-Fang Li; Xi-Zhao Li; Jiang-Bo Zhang; Tong-Min Wang; Fang Wang; Huan-Lin Yu; Qi-Sheng Feng; Li-Zhen Chen; Su-Mei Cao; Qing Liu; Jianbing Mu; Wei-Hua Jia
Journal:  J Infect Dis       Date:  2019-01-09       Impact factor: 5.226

4.  Smoking and Epstein-Barr virus infection in multiple sclerosis development.

Authors:  Tomas Olsson; Lars Alfredsson; Anna Karin Hedström; Jesse Huang; Nicole Brenner; Julia Butt; Jan Hillert; Tim Waterboer; Ingrid Kockum
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

5.  Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.

Authors:  Lingzhi Liu; Lielian Zuo; Jing Yang; Shuyu Xin; Jing Zhang; Jianhua Zhou; Guiyuan Li; Jinyong Tang; Jianhong Lu
Journal:  Cancer Med       Date:  2019-05-07       Impact factor: 4.452

Review 6.  Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker.

Authors:  Wai Kei Jacky Lam; Kwan Chee Allen Chan; Yuk Ming Dennis Lo
Journal:  J Pathol       Date:  2019-02-25       Impact factor: 7.996

7.  Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases.

Authors:  W K Jacky Lam; Peiyong Jiang; K C Allen Chan; Wenlei Peng; Huimin Shang; Macy M S Heung; Suk Hang Cheng; Haiqiang Zhang; O Y Olivia Tse; Radha Raghupathy; Brigette B Y Ma; Edwin P Hui; Anthony T C Chan; John K S Woo; Rossa W K Chiu; Y M Dennis Lo
Journal:  Nat Commun       Date:  2019-07-22       Impact factor: 14.919

8.  Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.

Authors:  Cheng Lin; Keyu Lin; Bin Zhang; Ying Su; Qiaojuan Guo; Tianzhu Lu; Yuanji Xu; Shaojun Lin; Jingfeng Zong; Jianji Pan
Journal:  Oncologist       Date:  2022-04-05       Impact factor: 5.837

9.  Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.

Authors:  John Malcolm Nicholls; Victor Ho-Fun Lee; Sik-Kwan Chan; Ka-Chun Tsang; Cheuk-Wai Choi; Dora Lai-Wan Kwong; Ka-On Lam; Sum-Yin Chan; Chi-Chung Tong; Tsz-Him So; To-Wai Leung; Mai-Yee Luk; Pek-Lan Khong; Anne Wing-Mui Lee
Journal:  Br J Cancer       Date:  2019-09-17       Impact factor: 7.640

Review 10.  Extracellular Vesicles in Head and Neck Cancer: A Potential New Trend in Diagnosis, Prognosis, and Treatment.

Authors:  Xinyu Qu; Jing-Woei Li; Jason Chan; Katie Meehan
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.